A one-plasmid system to generate influenza virus in cultured chicken cells for potential use in influenza vaccine

Journal of Virology

Volumn 83, Issue 18, 2009, Pages 9296-9303

  Zhang, Xiangmin ^a   Kong, Wei ^a   Ashraf, Shamaila ^a   Curtiss III, Roy ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED DNA POLYMERASE ALPHA; INFLUENZA VACCINE; NUCLEOPROTEIN; PROTEIN SUBUNIT; RIBONUCLEOPROTEIN;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; CELL CULTURE; CHICKEN; GENETICS; HUMAN; HUMAN CELL; INFLUENZA VIRUS; MOLECULAR WEIGHT; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION;

ANIMALS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CHICKENS; MICROBIOLOGICAL TECHNIQUES; ORTHOMYXOVIRIDAE; PLASMIDS; PROMOTER REGIONS, GENETIC; TRANSFECTION; VIROLOGY; VIRUS REPLICATION;

ORTHOMYXOVIRIDAE;

EID: 69449100838     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00781-09     Document Type: Article

References (24)

1. Ascon, M. A., D. M. Hone, N. Walters, and D. W. Pascual. 1998. Oral immunization with a Salmonella Typhimurium vaccine vector expressing recombinant enterotoxigenic Escherichia coli K99 fimbriae elicits elevated antibody titers for protective immunity. Infect. Immun. 66:5470-5476.
2. Chen, Z., A. Aspelund, G. Kemble, and H. Jin. 2006. Genetic mapping of the cold-adapted phenotype of B/Ann Arbor/1/66, the master donor virus for live attenuated influenza vaccines (FluMist). Virology 345:416-423. (Pubitemid 43189900)
3. Curtiss, R., III, S. Y. Wanda, B. M. Gunn, X. Zhang, S. A. Tinge, V. Ananthnarayan, H. Mo, S. Wang, and W. Kong. 2009. Salmonella enterica serovar Typhimurium strains with regulated delayed attenuation in vivo. Infect. Immun. 77:1071-1082.
4. Darji, A., C. A. Guzman, B. Gerstel, P. Wachholz, K. N. Timmis, J. Wehland, T. Chakraborty, and S. Weiss. 1997. Oral somatic transgene vaccination using attenuated S. Typhimurium. Cell 91:765-775.
5. Dean, D. A. 1997. Import of plasmid DNA into the nucleus is sequence specific. Exp. Cell Res. 230:293-302.
6. Fodor, E., L. Devenish, O. G. Engelhardt, P. Palese, G. G. Brownlee, and A. Garcia-Sastre. 1999. Rescue of influenza A virus from recombinant DNA. J. Virol. 73:9679-9682. (Pubitemid 29487131)
7. Gerdil, C. 2003. The annual production cycle for influenza vaccine. Vaccine 21:1776-1779. (Pubitemid 36398372)
8. Grillot-Courvalin, C., S. Goussard, and P. Courvalin. 1999. Bacteria as gene delivery vectors for mammalian cells. Curr. Opin. Biotechnol. 10:477-481.
9. Hoffmann, E., G. Neumann, G. Hobom, R. G. Webster, and Y. Kawaoka. 2000. "Ambisense" approach for the generation of influenza A virus: vRNA and mRNA synthesis from one template. Virology 267:310-317.
10. Jin, H., B. Lu, H. Zhou, C. Ma, J. Zhao, C. F. Yang, G. Kemble, and H. Greenberg. 2003. Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60. Virology 306:18-24. (Pubitemid 36293391)
11. Klumpp, K., R. W. Ruigrok, and F. Baudin. 1997. Roles of the influenza virus polymerase and nucleoprotein in forming a functional RNP structure. EMBO J. 16:1248-1257. (Pubitemid 27136091)
12. Lamb, R. A., and P. W. Choppin. 1983. The gene structure and replication of influenza virus. Annu. Rev. Biochem. 52:467-506.
13. Lewis, G. K. 2007. Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet? Expert Rev. Vaccines 6:431-440.
14. Massin, P., P. Rodrigues, M. Marasescu, S. van der Werf, and N. Naffakh. 2005. Cloning of the chicken RNA polymerase I promoter and use for reverse genetics of influenza A viruses in avian cells. J. Virol. 79:13811-13816. (Pubitemid 41508194)
15. Murti, K. G., R. G. Webster, and I. M. Jones. 1988. Localization of RNA polymerases on influenza viral ribonucleoproteins by immunogold labeling. Virology 164:562-566.
16. Neumann, G., K. Fujii, Y. Kino, and Y. Kawaoka. 2005. An improved reverse genetics system for influenza A virus generation and its implications for vaccine production. Proc. Natl. Acad. Sci. USA 102:16825-16829.
17. Neumann, G., T. Watanabe, H. Ito, S. Watanabe, H. Goto, P. Gao, M. Hughes, D. R. Perez, R. Donis, E. Hoffmann, G. Hobom, and Y. Kawaoka. 1999. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl. Acad. Sci. USA 96:9345-9350.
18. Noda, T., H. Sagara, A. Yen, A. Takada, H. Kida, R. H. Cheng, and Y. Kawaoka. 2006. Architecture of ribonucleoprotein complexes in influenza A virus particles. Nature 439:490-492. (Pubitemid 43152841)
19. Ozaki, H., E. A. Govorkova, C. Li, X. Xiong, R. G. Webster, and R. J. Webby. 2004. Generation of high-yielding influenza A viruses in African green monkey kidney (Vero) cells by reverse genetics. J. Virol. 78:1851-1857. (Pubitemid 38176716)
20. Rand, K. N. 1996. Crystal violet can be used to visualize DNA bands during gel electrophoresis and to improve cloning efficiency. Tech. Tips Online 1(1):23-24. http://www.science-direct.com/science/journal/13662120.
21. Schoen, C., J. Stritzker, W. Goebel, and S. Pilgrim. 2004. Bacteria as DNA vaccine carriers for genetic immunization. Int. J. Med. Microbiol. 294:319-335.
22. Sizemore, D. R., A. A. Branstrom, and J. C. Sadoff. 1995. Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization. Science 270:299-302.
23. Weiss, S., and S. Krusch. 2001. Bacteria-mediated transfer of eukaryotic expression plasmids into mammalian host cells. Biol. Chem. 382:533-541.
24. Zhou, R., R. C. Geiger, and D. A. Dean. 2004. Intracellular trafficking of nucleic acids. Expert Opin. Drug Deliv. 1:127-140.